FDA awards $1.487 million grant to U-M School of Nursing professor studying stimulant use disorder trajectories

U-M School of Nursing Professor and Director, Center for the Study of Drugs, Alcohol, Smoking and Health (DASH) Sean Esteban McCabe, Ph.D., was awarded a $1,487,081 by the U.S. Food and Drug Administration. McCabe’s project titled, “A Mosaic Approach for Understanding Stimulant Use, Misuse and Use Disorder Trajectories”, will examine individuals who are prescribed stimulants for ADHD nationally to determine who is at greatest risk for transitioning to later illicit stimulant misuse (e.g., cocaine, methamphetamine), other drug misuse, and stimulant/other drug use disorders. Additionally, McCabe’s project aims to identify the stimulant misuse trajectories and determine risk and protective factors associated with developing stimulant or other drug use disorders. As the grant’s principal investigator, McCabe will work on the project with the following scientific investigators and collaborators: Olivia Figueroa (University of Michigan), Kathryn Lundquist (University of Michigan), Dr. Vita McCabe (University of Michigan), Dr. Ty Schepis (Texas State University), Dr. John Schulenberg (University of Michigan), Phil Veliz, Ph.D. (University of Michigan), Kennedy Werner (Wayne State University), and Dr. Tim Wilens (Harvard University).